234 related articles for article (PubMed ID: 31779634)
1. GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy.
Shiraki A; Oyama JI; Nishikido T; Node K
Cardiovasc Diabetol; 2019 Nov; 18(1):164. PubMed ID: 31779634
[TBL] [Abstract][Full Text] [Related]
2. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
[TBL] [Abstract][Full Text] [Related]
4. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling.
Naruse G; Kanamori H; Yoshida A; Minatoguchi S; Kawaguchi T; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S
Cardiovasc Res; 2019 Nov; 115(13):1873-1885. PubMed ID: 30629149
[TBL] [Abstract][Full Text] [Related]
5. Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure.
Nonaka M; Morimoto S; Murayama T; Kurebayashi N; Li L; Wang YY; Arioka M; Yoshihara T; Takahashi-Yanaga F; Sasaguri T
Br J Pharmacol; 2015 May; 172(9):2369-82. PubMed ID: 25560565
[TBL] [Abstract][Full Text] [Related]
6. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
[TBL] [Abstract][Full Text] [Related]
7. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy.
Wang L; Cai Y; Jian L; Cheung CW; Zhang L; Xia Z
Cardiovasc Diabetol; 2021 Jan; 20(1):2. PubMed ID: 33397369
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism.
Sung MM; Das SK; Levasseur J; Byrne NJ; Fung D; Kim TT; Masson G; Boisvenue J; Soltys CL; Oudit GY; Dyck JR
Circ Heart Fail; 2015 Jan; 8(1):128-37. PubMed ID: 25394648
[TBL] [Abstract][Full Text] [Related]
10. Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.
Galvao TF; Khairallah RJ; Dabkowski ER; Brown BH; Hecker PA; O'Connell KA; O'Shea KM; Sabbah HN; Rastogi S; Daneault C; Des Rosiers C; Stanley WC
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(1):H12-21. PubMed ID: 23103493
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction.
Nguyen TD; Shingu Y; Amorim PA; Schenkl C; Schwarzer M; Doenst T
J Cardiovasc Transl Res; 2018 Jun; 11(3):259-267. PubMed ID: 29464655
[TBL] [Abstract][Full Text] [Related]
12. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure.
Uddin GM; Zhang L; Shah S; Fukushima A; Wagg CS; Gopal K; Al Batran R; Pherwani S; Ho KL; Boisvenue J; Karwi QG; Altamimi T; Wishart DS; Dyck JRB; Ussher JR; Oudit GY; Lopaschuk GD
Cardiovasc Diabetol; 2019 Jul; 18(1):86. PubMed ID: 31277657
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
[TBL] [Abstract][Full Text] [Related]
14. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
[TBL] [Abstract][Full Text] [Related]
15. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
[TBL] [Abstract][Full Text] [Related]
16. Metabolic manipulation in chronic heart failure: study protocol for a randomised controlled trial.
Beadle RM; Williams LK; Abozguia K; Patel K; Leon FL; Yousef Z; Wagenmakers A; Frenneaux MP
Trials; 2011 Jun; 12():140. PubMed ID: 21645332
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy.
Ishii S; Inomata T; Ikeda Y; Nabeta T; Iwamoto M; Watanabe I; Naruke T; Shinagawa H; Koitabashi T; Nishii M; Takeuchi I; Izumi T
Heart Vessels; 2014 Jan; 29(1):88-96. PubMed ID: 23519525
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction.
Kyhl K; Lønborg J; Hartmann B; Kissow H; Poulsen SS; Ali HE; Kjær A; Dela F; Engstrøm T; Treiman M
Peptides; 2017 Jul; 93():1-12. PubMed ID: 28460895
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy.
Wang D; Gladysheva IP; Fan TH; Sullivan R; Houng AK; Reed GL
Hypertension; 2014 Mar; 63(3):514-9. PubMed ID: 24379183
[TBL] [Abstract][Full Text] [Related]
20. Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy.
Beadle RM; Williams LK; Kuehl M; Bowater S; Abozguia K; Leyva F; Yousef Z; Wagenmakers AJ; Thies F; Horowitz J; Frenneaux MP
JACC Heart Fail; 2015 Mar; 3(3):202-11. PubMed ID: 25650370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
